IMAGE

Figure 8

ID
ZDB-IMAGE-231002-436
Source
Figures for Karolczak et al., 2023
Image
Figure Caption

Figure 8 DNM2 inhibition rescues the mtm cholestatic phenotype.

A targeted panel of chemicals was tested in mtm zebrafish, using the BODIPY assay as a screen for the cholestatic liver phenotype. For each chemical, the percentage of mtm zebrafish with positive staining in the gallbladder was measured as the readout (n = 10 per trial, with 1 replicate per trial). (A) Two DNM2 inhibitors, Dynasore (green arrow) and Dyngo-4a (pink arrow), were among the chemicals that produced the highest percentage of BODIPY+ larvae. (B) Validation of Dynasore combining 3 independent replicates of 10 larvae per replicate. Dynasore-treated mtm larvae had improved bile flux compared with their DMSO-treated mtm siblings (Dynasore = 30.6%, DMSO = 3.67%, P = 0.019, by 2-sided Fisher’s exact test) and did not differ significantly from their WT DMSO-treated siblings (WT percentage = 56.7%, Dynasore percentage = 30.6%, P = 0.13, 2-sided Fisher’s exact test). (C) Dynasore partially restored canalicular structure and transporter expression. Coimmunostaining was performed on whole-mount embryos either exposed to DMSO or treated with Dynasore. As expected, in DMSO-treated mtm zebrafish, essentially no Mdr1 staining was appreciated. In Dynasore-treated larvae, however, there was robust reexpression of Mdr1 and proper colocalization with Rab11. Scale bars: 20 μm.

Acknowledgments
This image is the copyrighted work of the attributed author or publisher, and ZFIN has permission only to display this image to its users. Additional permissions should be obtained from the applicable author or publisher of the image. Full text @ Journal of Clin. Invest.